Presentation is loading. Please wait.

Presentation is loading. Please wait.

A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under.

Similar presentations


Presentation on theme: "A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under."— Presentation transcript:

1 A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3) – β – d- glucan chromogenic assay in serum samples  J. Acosta, M. Catalan, A. del Palacio-Peréz-Medel, D. Lora, J.-C. Montejo, M.-S. Cuetara, M.-D. Moragues, J. Ponton, A. del Palacio  Clinical Microbiology and Infection  Volume 17, Issue 7, Pages (July 2011) DOI: /j x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

2 FIG. 1. Area under the curve (AUC) of receiver-operating curves (ROC) for: (a) all invasive aspergillosis (IA) cases, proven and probable; (b) proven IA cases; and (c) all invasive fungal disease cases (IA and P. jirovecii pneumonia). In case of IA (proven and probable), the AUC for GM in BAL was significantly higher than GM and BG in serum (p and p , respectively). In cases of proven IA, there was no significant difference between the AUC for GM in BAL when compared with the AUC for GM and BG in serum (p and p 0.159, respectively). Clinical Microbiology and Infection  , DOI: ( /j x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions


Download ppt "A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under."

Similar presentations


Ads by Google